Measures Selected

• The percentage of patients on long-term opioid therapy who are taking 50 MMEs or more per day
• The percentage of patients on long-term opioid therapy who received a prescription for a benzodiazepine
• The percentage of patients on long-term opioid therapy who had at least quarterly pain and functional assessments
• The percentage of patients on long-term opioid therapy with documentation that a urine drug test was performed at least annually
• The percentage of patients on long-term opioid therapy who were counseled on the purpose and use of naloxone, and prescribed naloxone